Close Menu

NEW YORK (GenomeWeb) – NanoString Technologies reported after the close of the market Thursday that its total revenues for the fourth quarter of 2018 were down about 15 percent year over year, while its product and services revenue grew 12 percent.

For the three months ended Dec. 31, 2018, total revenues dropped to $30.0 million from $35.2 million in Q4 2017, beating the average Wall Street estimate of $29.4 million.

The firm said it took in $23.6 million in product and service revenue in the quarter, a 12 percent increase from $21.0 million in Q4 2017.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.